{"id":1198,"date":"2009-01-01T12:00:00","date_gmt":"2009-01-01T11:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2009\/neue-arzneimittel-2007"},"modified":"2009-01-01T12:00:00","modified_gmt":"2009-01-01T11:00:00","slug":"neue-arzneimittel-2007","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/2009\/neue-arzneimittel-2007","title":{"rendered":"Neue Arzneimittel 2007"},"content":{"rendered":"<p>Zusammenfassung: Im Jahr 2007 sind 31 Arzneimittel neu zugelassen worden. Davon hatten 17 eine neuartige Struktur oder ein neuartiges Wirkprinzip, bei f\u00fcnf waren Pharmakokinetik oder Pharmakodynamik verbessert und f\u00fcnf waren Analogpr\u00e4parate ohne Innovation und Zusatznutzen. Lumiracoxib musste im gleichen Jahr wegen Lebertoxizit\u00e4t wieder vom Markt genommen werden. Bei Vareniclin ergaben sich Hinweise auf gef\u00e4hrliche psychiatrische [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Zusammenfassung: Im Jahr 2007 sind 31 Arzneimittel neu zugelassen worden. Davon hatten 17 eine neuartige Struktur oder ein neuartiges Wirkprinzip, bei f\u00fcnf waren Pharmakokinetik oder Pharmakodynamik verbessert und f\u00fcnf waren Analogpr\u00e4parate ohne Innovation und Zusatznutzen. Lumiracoxib musste im gleichen Jahr wegen Lebertoxizit\u00e4t wieder vom Markt genommen werden. Bei Vareniclin ergaben sich Hinweise auf gef\u00e4hrliche psychiatrische [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[1986,122,1108,1279,2971,123,523,524,2979,2939,324,526,2978,2974,2977,2095,1355,1360,723,155,2975,2976,2946,2872,2972,1615,1612,2822,2097,2973,2101,1310,2989,1111,125,2950,2100,2102,2990,2098,2953,325,2958,1455,1309,2544,2980,976,2994,2982,2993,2992,2988,2996,2985,2986,2947,1136,2995,1177,157,2981,2991,2952,2987,230,1137,2983,2984,514,2968,784,782,2964,1067,2962,1345,1441,2966,2963,2930,2965,2970,2967,2549,520,521,2969,2090,783,1350],"class_list":["post-1198","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-abatacept","tag-aids","tag-aliskiren","tag-anaemie","tag-anidulafungin","tag-antiretrovirale-therapie","tag-arzneimittelverordnungen","tag-arzneiverordnungen","tag-arzneiverordnungs-report-2008","tag-betain","tag-blutdruck","tag-buchbesprechung","tag-candidiasis","tag-chorea-huntington","tag-cilostazol","tag-condylomata-acuminata","tag-cox-2-hemmer","tag-coxibe","tag-darunavir","tag-diabetes-mellitus-typ-2","tag-echokardiografie","tag-echokardiographie","tag-eculizumab","tag-epoetin-delta","tag-eptotermin-alfa","tag-erythropoese-stimulierende-wirkstoffe","tag-esa","tag-exenatid","tag-feigwarzen","tag-gadoversetamid","tag-genitalwarzen","tag-gliptine","tag-hautinfektionen","tag-hepatitis-b","tag-hiv-infektion","tag-homozystinurie","tag-hpv","tag-hpv-impfung","tag-humaner-papillomvirus-impfstoff-typ-1618-cervarix","tag-humanes-papillom-virus","tag-hunter-syndrom","tag-hypertonie","tag-idursulfase","tag-impfung","tag-inkretinmimetika","tag-kleinwuchs","tag-laron-syndrom","tag-lenalidomid","tag-lennox-gastaut-syndrom","tag-lumiracoxib","tag-magnetresonanz-angiografie","tag-magnetresonanz-angiographie","tag-makuladegeneration","tag-maraviroc","tag-mecasermin","tag-methoxy-polyethylenglykol-epoetin-beta","tag-mukopolysaccharidose-typ-ii","tag-multiples-myelom","tag-nelarabin","tag-nierenzellkarzinom","tag-orale-antidiabetika","tag-paliperidon","tag-papillom-virus","tag-paroxysmale-naechtliche-haemoglobinurie","tag-perflutren","tag-periphere-arterielle-verschlusskrankheit","tag-plasmozytom","tag-prexige","tag-pseudarthrose","tag-pulmonale-hypertonie","tag-ranibizumab","tag-rauchen","tag-raucherentwoehnung","tag-retapamulin","tag-rheumatoide-arthritis","tag-rufinamid","tag-schizophrenie","tag-sitagliptin","tag-t-zell-leukaemie","tag-telbivudin","tag-temsirolimus","tag-tetrabenazin","tag-trabectedin","tag-trepostinil","tag-vareniclin","tag-verordnungsverhalten","tag-verschreibungsverhalten","tag-weichteilsarkome","tag-zervixkarzinom","tag-zigarettenrauchen","tag-zyklooxygenase-2-hemmer"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=1198"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/1198\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=1198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=1198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=1198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}